More About Clinical Trials

Do you know enough about Clinical Trials? Clinical trials are research studies conducted to evaluate different intervention, for example testing a new drug or an attempt to prevent disease activity (or both!) They help researchers determine if the intervention is safe, effective, and potentially better than the standard or current therapeutic options. The research conducted in trials has the potential to improve our lives and the lives of millions around the world. For these reasons, AiArthritis strongly supports participation in clinical trials if it is deemed the best therapeutic decision for the individual.

Our Clinical Trial Shared-Decision Making Tool was designed with our patient peers in mind. The tool was developed by patient research partners, patients, and research professionals who are expert in shared-decision making aid development.

Community and Individual Needs

At our organization, those with lived experience (the patients, parents of juveniles, care persons for adult patients) - and their perspectives, opinions, and individualized needs are at the core of all we do. We listen, we communicate, and then assess what we can do to help those affected by AiArthritis diseases in ways that are both personalized and collaborative.

Over the last several years, we have invested thousands of hours participating in information patient-peer discussions, as well as patient-led focus group research - both aimed at collecting data to help researchers understand what patients want most.  What we've found:

• Most people affected by AiArthritis diseases do not believe there is such as thing as "one treatment" to manage their disease (which often also includes co-morbidities).  Additionally, most prefer a mix of pharmacologic and non-pharmacologic interventions.
• Atypical might be more common than Typical.
• What works for one doesn't work for all.
• Access to treatments, fear of treatment side effects, and maintaining disease control are top drivers when choosing therapeutic management plans.



These statements are based on research conducted in our A Community Team (ACT) project and observing comments within patient groups and advisory panel discussions.

Why Would I Participate?

What about possible benefits and risks associated with clinical trials? One thing we want those recruiting for trials to understand is the 'why' a patient with AiArthritis diseases may choose to participate in a study. Those affected by AiArthritis diseases want their chosen therapies to improve quality of life and control the disease and its progression. Decisions to change treatments - whether that be by participating in a clinical trial or otherwise - is strongly driven by the need for continuity of care. Therefore, if a person with an AiArthritis disease is currently well managed on their existing therapy, it would likely not be recommended to stop treatment and start a new therapy being tested in a clinical trial. However, patients with refractory disease (hard to treat), who have experienced continual failures on other medications, or who have issues accessing treatments otherwise, may be great candidates to explore participating in clinical trials.

Can I participate? Clinical trials have inclusion and exclusion criteria, which dictates who can participate in the research study.  These requirements are necessary to have to that those studying the intervention can analyze what is working (or not working) in a larger group of people.  This also enables them to measure the probability that the therapy will be effective and safe.  But in diseases, like those that are "auto" (autoimmune/autoinflammatory) - where both onset and progression can vary greatly per individual - these limitations can produce results that are true in only a percentage of the population (i.e. those who are most alike).

If you are interested in participating, visit the site that explains more about the trial - and there you should be able to find out if you meet their criteria. If it's not listed, there will be a contact person mentioned - reach out and they will provide you with more information.

As we move into a world of precision medicine - which studies things like biomarkers (blood, body fluids), genetics, and patient subgroups, the design of research (and clinical trials) will change. We are addressing this in our Preparing Patients for Precision Medicine Trials project.

Thinking about joining a clinical trial? Whether you are just starting to think about it OR found one and want to start weighing the pros and cons, here is a tool for you!

OR - download if you are a healthcare professional and are either interesting in learning more about this tool or possibly considering sharing with patients.